Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2018

Jan 31, 2018

29745_dirs_2018-01-31_a5dd2c12-f67f-407e-934a-c8fda5726419.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2018-01-29

Reporting Person: Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-01-29 Common Stock A 12437 $87.60 Acquired 126654 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-01-29 Restricted Stock Unit $ A 12222 Acquired 2019-02-01 Common Stock (12222.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 5047 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.